Evidence map›Paper›PMID 33071947›Full record

ArticleFrontiers in neurology2020

Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy.

Jiapeng Zhang, Qi Meng, Jingzi Zhong, Min Zhang, Xiao Qin, Xiaohua Ni, Jiawen Ma, Yangwen He, Dan Zeng, Dan Lan

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy.International journal of molecular sciences · 2024
    Review
  2. Treatment with ataluren in four symptomatic Duchenne carriers. A pilot study.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2024
    Article
  3. A Nonsense Variant in theAnimals : an open access journal from MDPI · 2022
    Article
  4. Article
  5. Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jiapeng ZhangDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Qi MengDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jingzi ZhongDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Min ZhangDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xiao QinDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xiaohua NiDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jiawen MaDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yangwen HeDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Dan ZengDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Dan LanDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerscreatine kinaseduchenne/becker muscular dystrophyfemale carriersmicroRNAsmyomiRs

Identifiers

PMID33071947
PMCPMC7530632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.